Diz José C, Luna-Rojas Pedro, Díaz-Vidal Pablo, Fernández-Vázquez Uxía, Gil-Casado Cristina, Diz-Ferreira Eva
From the Department of Functional Biology and Health Sciences, Well-Move Research Group, University of Vigo, Vigo, Spain.
Department of Anaesthesia and Postoperative Critical Care, Hospital Alvaro Cunqueiro, Vigo, Spain.
Anesth Analg. 2025 Jul 1;141(1):152-161. doi: 10.1213/ANE.0000000000007368. Epub 2025 Jan 20.
Some studies suggest that balanced solutions may improve outcomes in critical care patients. However, in patients with traumatic brain injury (TBI) existing data indicate that normal saline may be preferred. We hypothesized that mortality in critically ill patients with and without TBI would differ with the use of balanced salt solutions versus normal saline.
We conducted a systematic review and meta-analysis to investigate the impact of balanced crystalloids versus normal saline on 90-day mortality in adult critical care patients with and without TBI. Secondary outcomes included length of hospital stay, renal complications, need for vasopressors or mechanical ventilation, and mortality in critically ill patients with sepsis. We followed the PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analysis) statement and estimated the odds ratio (OR) and 95% confidence interval (CI) with a random-effects model.
We included 15 clinical trials involving 35,207 patients. The OR of mortality with balanced solutions versus saline in patients without TBI was 0.93 (95% CI, 0.87-0.98; P = .01; I 2 = 0%), while the OR for mortality in patients with TBI was 1.31 (95% CI, 1.03-1.65; P = .03; I 2 = 0%). We found no differences in secondary outcomes due to fluid choice although data were unavailable to calculate pooled estimates for some of the secondary outcomes for TBI patients. In patients with sepsis, the OR of mortality with balanced solutions was 0.92 (95% CI, 0.83-1.02; I 2 = 0%).
In comparison to normal saline, balanced solutions were associated with a reduction in mortality in critical care patients without TBI. However, balanced solutions were associated with an increase in mortality in patients with TBI. These findings suggest that the effect of fluid choice on intensive care unit (ICU) outcomes may depend partially on the type of critical illness and in particular in patients with TBI.
一些研究表明,平衡液可能会改善重症患者的预后。然而,对于创伤性脑损伤(TBI)患者,现有数据表明生理盐水可能更受青睐。我们假设,使用平衡盐溶液与生理盐水相比,伴有和不伴有TBI的重症患者的死亡率会有所不同。
我们进行了一项系统评价和荟萃分析,以研究平衡晶体液与生理盐水对伴有和不伴有TBI的成年重症患者90天死亡率的影响。次要结局包括住院时间、肾脏并发症、使用血管升压药或机械通气的需求,以及脓毒症重症患者的死亡率。我们遵循PRISMA(系统评价和荟萃分析的首选报告项目)声明,并使用随机效应模型估计比值比(OR)和95%置信区间(CI)。
我们纳入了15项临床试验,涉及35207例患者。在没有TBI的患者中,使用平衡液与生理盐水相比的死亡率OR为0.93(95%CI,0.87-0.98;P = 0.01;I² = 0%),而TBI患者的死亡率OR为1.31(95%CI,1.03-1.65;P = 0.03;I² = 0%)。尽管没有数据可用于计算TBI患者某些次要结局的合并估计值,但我们发现因液体选择导致的次要结局没有差异。在脓毒症患者中,使用平衡液的死亡率OR为0.92(95%CI,0.83-1.02;I² = 0%)。
与生理盐水相比,平衡液与没有TBI的重症患者死亡率降低相关。然而,平衡液与TBI患者死亡率增加相关。这些发现表明,液体选择对重症监护病房(ICU)结局的影响可能部分取决于危重病的类型,特别是TBI患者。